| 1 | 19273679 | Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal beta-lactam resistance in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2009 Jun |
5 |
| 2 | 22005996 | Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 2012 Jan |
3 |
| 3 | 23089750 | High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms. | Antimicrob Agents Chemother | 2013 Jan |
2 |
| 4 | 28850797 | A Rapid Phenotypic Whole-Cell Screening Approach for the Identification of Small-Molecule Inhibitors That Counter β-Lactamase Resistance in Pseudomonas aeruginosa. | SLAS Discov | 2018 Jan |
4 |
| 5 | 31740559 | Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants. | Antimicrob Agents Chemother | 2020 Jan 27 |
1 |
| 6 | 32660987 | Adding Insult to Injury: Mechanistic Basis for How AmpC Mutations Allow Pseudomonas aeruginosa To Accelerate Cephalosporin Hydrolysis and Evade Avibactam. | Antimicrob Agents Chemother | 2020 Aug 20 |
12 |